Cargando…

Feasibility, Acceptability, and Adherence with Short-Term HIV Preexposure Prophylaxis in Female Sexual Partners of Migrant Miners in Mozambique

Preexposure prophylaxis (PrEP) offers protection from HIV acquisition if taken as prescribed. We evaluated the feasibility, acceptability, and adherence with short-term PrEP among female sexual partners of migrant miners in Mozambique. METHODS: HIV-negative female sexual partners of migrant miners w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lahuerta, Maria, Zerbe, Allison, Baggaley, Rachel, Falcao, Joana, Ahoua, Laurence, DiMattei, Pietro, Morales, Fernando, Ramiro, Isaias, El-Sadr, Wafaa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2017
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662163/ https://www.ncbi.nlm.nih.gov/pubmed/28777264 http://dx.doi.org/10.1097/QAI.0000000000001518

Ejemplares similares

Advanced Human Immunodeficiency Virus Disease at Diagnosis in Mozambique and Swaziland
por: Kujawski, Stephanie A, et al.
Publicado: (2017)

Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
por: Fonner, Virginia A., et al.
Publicado: (2016)

The European preexposure prophylaxis revolution
por: Cairns, Gus, et al.
Publicado: (2016)

Response Rates of Medical Providers to Internet Surveys Regarding Their Adoption of Preexposure Prophylaxis for HIV: Methodological Implications
por: Silverman, Thomas B., et al.
Publicado: (2018)

Eligibility for HIV Preexposure Prophylaxis, Intention to Use Preexposure Prophylaxis, and Informal Use of Preexposure Prophylaxis Among Men Who Have Sex With Men in Amsterdam, the Netherlands
por: Hulstein, Sebastiaan H., et al.
Publicado: (2021)

The use of preexposure treatments for HIV prophylaxis
por: Majid, Adrian, et al.
Publicado: (2012)

Statistical issues in trials of preexposure prophylaxis
por: Dunn, David T., et al.
Publicado: (2016)

Seasonal PrEP for partners of migrant miners in southern Mozambique: a highly focused PrEP intervention
por: Cremin, Ide, et al.
Publicado: (2015)

Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women
por: Anderson, Peter L., et al.
Publicado: (2016)

Oral preexposure prophylaxis continuation, measurement and reporting
por: Stankevitz, Kayla, et al.
Publicado: (2020)

Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition
por: Fonner, Virginia A., et al.
Publicado: (2023)

P41 - Preexposure prophylaxis of infants’ food allergy
por: Denisova, Svetlana, et al.
Publicado: (2014)

Effect of 6-Month HIV Preexposure Prophylaxis Dispensing With Interim Self-testing on Preexposure Prophylaxis Continuation at 12 Months: A Randomized Noninferiority Trial
por: Ortblad, Katrina F., et al.
Publicado: (2023)

Adherence to Preexposure Prophylaxis: Current, Emerging, and Anticipated Bases of Evidence
por: Amico, K. Rivet, et al.
Publicado: (2014)

Weighing the Risk of Drug Resistance With the Benefits of HIV Preexposure Prophylaxis
por: Grant, Robert M., et al.
Publicado: (2015)

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion
por: Donnell, Deborah, et al.
Publicado: (2017)

Preexposure Prophylaxis for the Prevention of HIV Infection — 2014 Available Online
Publicado: (2014)

Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States
por: Aaron, Erika, et al.
Publicado: (2018)

HIV Preexposure Prophylaxis in the U.S. Military Services — 2014–2016
por: Blaylock, Jason M., et al.
Publicado: (2018)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
por: Knox, David C., et al.
Publicado: (2022)

Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis
por: Ahluwalia, Amrit Kaur, et al.
Publicado: (2022)

Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis
por: Mirembe, Brenda G., et al.
Publicado: (2016)

Factors Associated with Late Antiretroviral Therapy Initiation among Adults in Mozambique
por: Lahuerta, Maria, et al.
Publicado: (2012)

MPrEP+ study protocol: a prospective cohort study assessing the feasibility and acceptability of an HIV pre-exposure prophylaxis (PrEP) strategy for male clients of female sex workers in Kisumu, Kenya
por: Mantell, Joanne, et al.
Publicado: (2022)

Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV
por: Nguyen, Vinh-Kim, et al.
Publicado: (2018)

A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis
por: Fuchs, Jonathan D., et al.
Publicado: (2018)

HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016
por: Huang, Ya-lin A., et al.
Publicado: (2018)

Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Preexposure prophylaxis strategies for African–American women affected by mass incarceration
por: Adams, Joëlla W., et al.
Publicado: (2021)

Women Trust Their OBGYNs to Provide Preexposure Prophylaxis: An Opportunity for HIV Prevention
por: Danvers, Antoinette A., et al.
Publicado: (2022)

Serological Screening Suggests Presence of Schmallenberg Virus in Cattle, Sheep and Goat in the Zambezia Province, Mozambique
por: Blomström, A-L, et al.
Publicado: (2014)

Feasibility and Acceptability of Health Communication Interventions Within a Combination Intervention Strategy for Improving Linkage and Retention in HIV Care in Mozambique
por: Sutton, Roberta, et al.
Publicado: (2017)

Measuring retention in care for HIV-positive pregnant women in Prevention of Mother-to-Child Transmission of HIV (PMTCT) option B+ programs: the Mozambique experience
por: Ahoua, Laurence, et al.
Publicado: (2020)

HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial
por: Liegler, Teri, et al.
Publicado: (2014)

Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care
por: Krakower, Douglas, et al.
Publicado: (2019)

Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020
por: Tanner, Mary R., et al.
Publicado: (2020)

Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM
por: Estcourt, Claudia, et al.
Publicado: (2021)

Occupational Health Update: Approach to Evaluation of Health Care Personnel and Preexposure Prophylaxis
por: Shenoy, Erica S., et al.
Publicado: (2021)

Predictors of Re-Initiation of Daily Oral Preexposure Prophylaxis Regimen After Discontinuation
por: Xavier Hall, Casey D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2jn6htqof465il61nhgb5b1i53